{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:56:52Z","timestamp":1778738212507,"version":"3.51.4"},"reference-count":247,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001026","name":"National Breast Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"DOI":"10.3389\/fcell.2019.00221","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T14:13:40Z","timestamp":1569939220000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Why Be One Protein When You Can Affect Many? The Multiple Roles of YB-1 in Lung Cancer and Mesothelioma"],"prefix":"10.3389","volume":"7","author":[{"given":"Thomas G.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Schelch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunali","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glen","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1021\/nn504508s","article-title":"Triggering of RNA Interference with RNA\u2013RNA, RNA\u2013DNA, and DNA\u2013RNA Nanoparticles.","volume":"9","author":"Afonin","year":"2014","journal-title":"ACS Nano"},{"key":"B2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.32607\/20758251-2017-9-2-4-16","article-title":"At the interface of three nucleic acids: the role of RNA-binding proteins and poly (ADP-ribose) in DNA repair.","volume":"9","author":"Alemasova","year":"2017","journal-title":"Acta Naturae"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.bbapap.2016.08.012","article-title":"Y-box-binding protein 1 as a non-canonical factor of base excision repair.","volume":"1864","author":"Alemasova","year":"2016","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"key":"B4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.biochi.2015.10.008","article-title":"Poly (ADP-ribosyl) ation as a new posttranslational modification of YB-1.","volume":"119","author":"Alemasova","year":"2015","journal-title":"Biochimie"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.81","article-title":"The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1.","volume":"28","author":"Astanehe","year":"2009","journal-title":"Oncogene"},{"key":"B6","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.bbcan.2012.04.008","article-title":"The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.","volume":"1826","author":"Bao","year":"2012","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s10637-016-0407-y","article-title":"Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors.","volume":"35","author":"Beg","year":"2017","journal-title":"Invest. New Drugs"},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.4253","article-title":"Reactive oxygen species a double-edged sword for mesothelioma.","volume":"6","author":"Benedetti","year":"2015","journal-title":"Oncotarget"},{"key":"B9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.canlet.2017.06.028","article-title":"Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.","volume":"405","author":"Betti","year":"2017","journal-title":"Cancer Lett."},{"key":"B10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/JTO.0000000000000055","article-title":"PI3K\/mTOR signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomy.","volume":"9","author":"Bitanihirwe","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22009","article-title":"The WAVE3-YB1 interaction regulates cancer stem cells activity in breast cancer.","volume":"8","author":"Bledzka","year":"2017","journal-title":"Oncotarget"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.celrep.2016.04.047","article-title":"Multiomic analysis of the UV-induced DNA damage response.","volume":"15","author":"Boeing","year":"2016","journal-title":"Cell Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/leu.2012.185","article-title":"The feed-forward loop between YB-1 and MYC is essential for multiple myeloma cell survival.","volume":"27","author":"Bommert","year":"2013","journal-title":"Leukemia"},{"key":"B14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrc3265","article-title":"To differentiate or not\u2014routes towards metastasis.","volume":"12","author":"Brabletz","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"259.e8","DOI":"10.1016\/j.cllc.2016.07.002","article-title":"Postoperative adjuvant systemic therapy in completely resected non\u2013small-cell lung cancer: a systematic review.","volume":"18","author":"Bradbury","year":"2017","journal-title":"Clin. Lung Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.2217\/fon-2017-0307","article-title":"A review of bevacizumab in the treatment of malignant pleural mesothelioma.","volume":"13","author":"Brosseau","year":"2017","journal-title":"Future Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations.","volume":"47","author":"Bueno","year":"2015","journal-title":"Nat. Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/cncr.29098","article-title":"Small cell lung cancer: where do we go from here?","volume":"121","author":"Byers","year":"2015","journal-title":"Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13733","article-title":"Y-box binding protein-1 promotes hepatocellular carcinoma-initiating cell progression and tumorigenesis via Wnt\/\u03b2-catenin pathway.","volume":"8","author":"Chao","year":"2017","journal-title":"Oncotarget"},{"key":"B21","first-page":"232","article-title":"Combination chemoimmunotherapy with interferon-alpha and cisplatin in patients with advanced non-small cell lung cancer.","volume":"56","author":"Chao","year":"1995","journal-title":"Zhonghua yi xue za zhi"},{"key":"B22","doi-asserted-by":"publisher","first-page":"7066","DOI":"10.1128\/MCB.00244-08","article-title":"Regulatory role of human AP-endonuclease (APE1\/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1.","volume":"28","author":"Chattopadhyay","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.3892\/etm.2019.7271","article-title":"MicroRNA-382 inhibits cancer cell growth and metastasis in NSCLC via targeting LMO3.","volume":"17","author":"Chen","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.bbrc.2018.01.022","article-title":"LncRNA GAS5 regulates ischemic stroke as a competing endogenous RNA for miR-137 to regulate the Notch1 signaling pathway.","volume":"496","author":"Chen","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.3892\/ol.2017.5904","article-title":"miR-137 inhibits the proliferation of human non-small cell lung cancer cells by targeting SRC3.","volume":"13","author":"Chen","year":"2017","journal-title":"Oncol. Lett."},{"key":"B26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.biopha.2016.12.007","article-title":"miR-382 inhibits tumor progression by targeting SETD8 in non-small cell lung cancer.","volume":"86","author":"Chen","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"B27","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.2741\/3782","article-title":"NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target.","volume":"16","author":"Chen","year":"2011","journal-title":"Front. Biosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.freeradbiomed.2015.05.002","article-title":"Malignant mesothelioma as an oxidative stress-induced cancer: an update.","volume":"86","author":"Chew","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jmb.2008.09.060","article-title":"RBBP6 interacts with multifunctional protein YB-1 through its RING finger domain, leading to ubiquitination and proteosomal degradation of YB-1.","volume":"384","author":"Chibi","year":"2008","journal-title":"J. Mol. Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"10433","DOI":"10.1158\/0008-5472.can-10-2638","article-title":"Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell\u2013like properties and epithelial\u2013mesenchymal transdifferentiation.","volume":"70","author":"Chiou","year":"2010","journal-title":"Cancer Res."},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.3186","article-title":"A novel HIF-1\u03b1-integrin-linked kinase regulatory loop that facilitates hypoxia-induced HIF-1\u03b1 expression and epithelial-mesenchymal transition in cancer cells.","volume":"6","author":"Chou","year":"2015","journal-title":"Oncotarget"},{"key":"B32","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/00001622-200403000-00008","article-title":"The role of EGFR inhibitors in nonsmall cell lung cancer.","volume":"16","author":"Ciardiello","year":"2004","journal-title":"Curr. Opin. Oncol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.31","article-title":"Upregulated c-myc expression in multiple myeloma by internal ribosome entry results from increased interactions with and expression of PTB-1 and YB-1.","volume":"29","author":"Cobbold","year":"2010","journal-title":"Oncogene"},{"key":"B34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/onc.2009.321","article-title":"Genotoxic stress-induced nuclear localization of oncoprotein YB-1 in the absence of proteolytic processing.","volume":"29","author":"Cohen","year":"2010","journal-title":"Oncogene"},{"key":"B35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.21873\/cgp.20023","article-title":"A proteomic analysis of the malignant mesothelioma secretome using iTRAQ.","volume":"14","author":"Creaney","year":"2017","journal-title":"Cancer Genomics Proteom."},{"key":"B36","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.stem.2007.08.012","article-title":"Cancer stem cells and tumor metastasis: first steps into uncharted territory.","volume":"1","author":"Dalerba","year":"2007","journal-title":"Cell Stem Cell"},{"key":"B37","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.4135","article-title":"Inhibition of RSK with the novel small-molecule inhibitor LJI308 overcomes chemoresistance by eliminating cancer stem cells.","volume":"6","author":"Davies","year":"2015","journal-title":"Oncotarget"},{"key":"B38","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1165\/rcmb.2009-0221OC","article-title":"Cigarette smoke induces nucleic-acid oxidation in lung fibroblasts.","volume":"43","author":"Deslee","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.lungcan.2005.10.016","article-title":"EGFR overexpression in malignant pleural mesothelioma: an immunohistochemical and molecular study with clinico-pathological correlations.","volume":"51","author":"Destro","year":"2006","journal-title":"Lung Cancer"},{"key":"B40","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/gtc.12373","article-title":"\u0394Np63\u03b1 controls YB-1 protein stability: evidence on YB-1 as a new player in keratinocyte differentiation.","volume":"21","author":"di Martino","year":"2016","journal-title":"Genes Cells"},{"key":"B41","doi-asserted-by":"crossref","first-page":"E7535","DOI":"10.1073\/pnas.1608585113","article-title":"Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer.","volume":"113","author":"Diaz-Lagares","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B42","doi-asserted-by":"publisher","first-page":"7322","DOI":"10.1073\/pnas.85.19.7322","article-title":"Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box.","volume":"85","author":"Didier","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s00018-014-1820-z","article-title":"New paradigms in the repair of oxidative damage in human genome: mechanisms ensuring repair of mutagenic base lesions during replication and involvement of accessory proteins.","volume":"72","author":"Dutta","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ccell.2015.04.003","article-title":"Translational activation of HIF1\u03b1 by YB-1 promotes sarcoma metastasis.","volume":"27","author":"El-Naggar","year":"2015","journal-title":"Cancer Cell"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1073\/pnas.0706790105","article-title":"PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a).","volume":"105","author":"Emerling","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B46","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ccr.2009.03.017","article-title":"Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition.","volume":"15","author":"Evdokimova","year":"","journal-title":"Cancer Cell"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.4161\/cc.8.18.9537","article-title":"Reduced proliferation and enhanced migration: two sides of the same coin? Molecular mechanisms of metastatic progression by YB-1.","volume":"8","author":"Evdokimova","year":"","journal-title":"Cell Cycle"},{"key":"B48","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.atherosclerosis.2018.09.020","article-title":"Cold shock Y-box binding protein-1 acetylation status in monocytes is associated with systemic inflammation and vascular damage.","volume":"278","author":"Ewert","year":"2018","journal-title":"Atherosclerosis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jbo.2017.01.002","article-title":"Serum YB-1 (Y-box binding protein 1) as a biomarker of bone disease progression in patients with breast cancer and bone metastases.","volume":"6","author":"Ferreira","year":"2017","journal-title":"J. Bone Oncol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1134\/S000629791502008X","article-title":"Y-box binding protein 1 (YB-1) promotes detection of DNA bulky lesions by XPC-HR23B factor.","volume":"80","author":"Fomina","year":"2015","journal-title":"Biochemistry"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-019-0613-x","article-title":"Use of immune checkpoint inhibitors in mesothelioma.","volume":"20","author":"Forde","year":"2019","journal-title":"Curr. Treat. Options Oncol."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00166","article-title":"Next generation sequencing and genetic alterations in squamous cell lung carcinoma: where are we today?","volume":"9","author":"Friedlaender","year":"2019","journal-title":"Front. Oncol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/embor.2009.81","article-title":"Y-box protein-1 is actively secreted through a non-classical pathway and acts as an extracellular mitogen.","volume":"10","author":"Frye","year":"2009","journal-title":"EMBO Rep."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"B55","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/nar\/gkh170","article-title":"YB-1 promotes strand separation in vitro of duplex DNA containing either mispaired bases or cisplatin modifications, exhibits endonucleolytic activities and binds several DNA repair proteins.","volume":"32","author":"Gaudreault","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.abb.2018.10.009","article-title":"The soluble ligand Ybox-1 activates Notch3 receptor by binding to epidermal growth factor like repeats 20-23.","volume":"660","author":"Gera","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"B57","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1183\/09031936.03.00033203","article-title":"Nuclear YB-1 expression as a negative prognostic marker in nonsmall cell lung cancer.","volume":"23","author":"Gessner","year":"2004","journal-title":"Eur. Respir. J."},{"key":"B58","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.3764","article-title":"YBX1\/YB-1 induces partial EMT and tumourigenicity through secretion of angiogenic factors into the extracellular microenvironment.","volume":"6","author":"Gopal","year":"2015","journal-title":"Oncotarget"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-970","article-title":"PROGgeneV2: enhancements on the existing database.","volume":"14","author":"Goswami","year":"2014","journal-title":"BMC Cancer"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/srep32643","article-title":"Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo.","volume":"6","author":"Greening","year":"2016","journal-title":"Sci. Rep."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/genes9100513","article-title":"Oxidative stress causes enhanced secretion of YB-1 Protein that restrains proliferation of receiving cells.","volume":"9","author":"Guarino","year":"2018","journal-title":"Genes."},{"key":"B62","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.cell.2014.10.032","article-title":"A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis.","volume":"159","author":"Gujral","year":"2014","journal-title":"Cell"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ejps.2017.09.019","article-title":"Identification of 2, 4-dihydroxy-5-pyrimidinyl imidothiocarbomate as a novel inhibitor to Y box binding protein-1 (YB-1) and its therapeutic actions against breast cancer.","volume":"116","author":"Gunasekaran","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.bbrc.2017.04.033","article-title":"Transcriptional activation of NANOG by YBX1 promotes lung cancer stem-like properties and metastasis.","volume":"487","author":"Guo","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B65","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10555-017-9718-5","article-title":"From biomarkers to therapeutic targets\u2014the promises and perils of long non-coding RNAs in cancer.","volume":"37","author":"Gutschner","year":"2018","journal-title":"Cancer Metastasis Rev."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082241","article-title":"Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer.","volume":"8","author":"Gy\u0151rffy","year":"2013","journal-title":"PLoS One"},{"key":"B67","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.bbrc.2015.01.114","article-title":"YB-1 overexpression promotes a TGF-\u03b21-induced epithelial\u2013mesenchymal transition via Akt activation.","volume":"458","author":"Ha","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B68","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s40572-017-0155-y","article-title":"Night shift work and risk of breast cancer.","volume":"4","author":"Hansen","year":"2017","journal-title":"Curr. Environ. Health Rep."},{"key":"B69","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/gtc.12150","article-title":"YB-1 promotes transcription of cyclin D1 in human non-small-cell lung cancers.","volume":"19","author":"Harada","year":"2014","journal-title":"Genes Cells"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/j.ajpath.2015.04.008","article-title":"Twist contributes to proliferation and epithelial-to-mesenchymal transition\u2013induced fibrosis by regulating YB-1 in human peritoneal mesothelial cells.","volume":"185","author":"He","year":"2015","journal-title":"Am. J. Pathol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","article-title":"Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer.","volume":"1","author":"Hermann","year":"2007","journal-title":"Cell Stem Cell"},{"key":"B72","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/s0140-6736(16)30958-8","article-title":"Lung cancer: current therapies and new targeted treatments.","volume":"389","author":"Hirsch","year":"2017","journal-title":"Lancet"},{"key":"B73","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1097\/JTO.0b013e31820e1a25","article-title":"Temsirolimus inhibits malignant pleural mesothelioma growth in vitro and in vivo: synergism with chemotherapy.","volume":"6","author":"Hoda","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cllc.2011.11.006","article-title":"Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.","volume":"13","author":"Hyogotani","year":"2012","journal-title":"Clin. Lung Cancer"},{"key":"B75","first-page":"342","article-title":"Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen.","volume":"59","author":"Ise","year":"1999","journal-title":"Cancer Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3978\/j.issn.2218-6751.2015.08.04","article-title":"Global trends of lung cancer mortality and smoking prevalence.","volume":"4","author":"Islami","year":"2015","journal-title":"Transl. Lung Cancer Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000356874","article-title":"Clinical significance of epithelial-mesenchymal transition-associated markers in malignant pleural mesothelioma.","volume":"86","author":"Iwanami","year":"2014","journal-title":"Oncology"},{"key":"B78","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa1616288","article-title":"Tracking the evolution of non\u2013small-cell lung cancer.","volume":"376","author":"Jamal-Hanjani","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrclinonc.2018.28","article-title":"Targeting the PI3K pathway in cancer: are we making headway?","volume":"15","author":"Janku","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3892\/mmr.2016.5978","article-title":"Antimicrobial peptide LL-37 promotes YB-1 expression, and the viability, migration and invasion of malignant melanoma cells.","volume":"15","author":"Jia","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14732","article-title":"Positive expression of Y-box binding protein 1 and prognosis in non-small cell lung cancer: a meta-analysis.","volume":"8","author":"Jiang","year":"2017","journal-title":"Oncotarget"},{"key":"B82","first-page":"2980","article-title":"Amplification and expression of the human cyclin D gene in esophageal cancer.","volume":"52","author":"Jiang","year":"1992","journal-title":"Cancer Res."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093937","article-title":"Association of XPC polymorphisms and lung cancer risk: a meta-analysis.","volume":"9","author":"Jin","year":"2014","journal-title":"PLoS One"},{"key":"B84","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jtho.2017.10.016","article-title":"Dysregulated expression of the MicroRNA miR-137 and its target YBX1 contribute to the invasive characteristics of malignant pleural mesothelioma.","volume":"13","author":"Johnson","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nrg3965","article-title":"Towards a molecular understanding of microRNA-mediated gene silencing.","volume":"16","author":"Jonas","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-328","article-title":"YB-1 regulates Sox2 to coordinately sustain stemness and tumorigenic properties in a phenotypically distinct subset of breast cancer cells.","volume":"14","author":"Jung","year":"2014","journal-title":"BMC Cancer"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1093\/jnci\/djt210","article-title":"Role of focal adhesion kinase in regulating YB\u20131\u2013mediated paclitaxel resistance in ovarian cancer.","volume":"105","author":"Kang","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"B88","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3978\/j.issn.2218-6751.2013.01.01","article-title":"The role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lung.","volume":"2","author":"Karachaliou","year":"2013","journal-title":"Transl. Lung Cancer Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1002\/pmic.200800852","article-title":"Phosphorylation of the SSBP2 and ABL proteins by the ZNF198-FGFR1 fusion kinase seen in atypical myeloproliferative disorders as revealed by phosphopeptide-specific MS.","volume":"9","author":"Kasyapa","year":"2009","journal-title":"Proteomics"},{"key":"B90","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.18632\/oncotarget.1790","article-title":"YB-1 expression promotes epithelial-to-mesenchymal transition in prostate cancer that is inhibited by a small molecule fisetin.","volume":"5","author":"Khan","year":"2014","journal-title":"Oncotarget"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1002\/ijc.26178","article-title":"Dual inhibition of phosphatidylinositol 3-kinase\/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin.","volume":"130","author":"Khan","year":"2012","journal-title":"Int. J. Cancer"},{"key":"B92","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/s0169-5002(00)00181-1","article-title":"Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis.","volume":"31","author":"Khuder","year":"2001","journal-title":"Lung Cancer"},{"key":"B93","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.4161\/cc.26670","article-title":"The proteolytic YB-1 fragment interacts with DNA repair machinery and enhances survival during DNA damaging stress.","volume":"12","author":"Kim","year":"2013","journal-title":"Cell Cycle"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4720-z","article-title":"Hypoxia promotes acquisition of aggressive phenotypes in human malignant mesothelioma.","volume":"18","author":"Kim","year":"2018","journal-title":"BMC Cancer"},{"key":"B95","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bbrc.2016.03.064","article-title":"Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells.","volume":"473","author":"Kobayashi","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B96","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/s0014-5793(97)01296-9","article-title":"Nuclear translocation of the Y-box binding protein by ultraviolet irradiation.","volume":"417","author":"Koike","year":"1997","journal-title":"FEBS Lett."},{"key":"B97","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejcb.2013.11.007","article-title":"Y-box binding protein 1\u2013a prognostic marker and target in tumour therapy.","volume":"93","author":"Kosnopfel","year":"2014","journal-title":"Eur. J. Cell Biol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1200\/JCO.2017.72.4401","article-title":"Adjuvant systemic therapy and adjuvant radiation therapy for stage I to IIIA completely resected non-small-cell lung cancers: American Society of Clinical Oncology\/Cancer Care Ontario clinical practice guideline update.","volume":"35","author":"Kris","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"7353","DOI":"10.1073\/pnas.1812876116","article-title":"Acquisition of a hybrid E\/M state is essential for tumorigenicity of basal breast cancer cells.","volume":"116","author":"Kr\u00f6ger","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B100","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1080\/15459624.2014.993472","article-title":"Night shift work and lung cancer risk among female textile workers in shanghai, china.","volume":"12","author":"Kwon","year":"2015","journal-title":"J. Occup. Environ. Hyg."},{"key":"B101","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.lungcan.2005.03.017","article-title":"Implications of P16\/CDKN2A deletion in pleural mesotheliomas.","volume":"49","author":"Ladanyi","year":"2005","journal-title":"Lung Cancer"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-6-148","article-title":"MVP and vaults: a role in the radiation response.","volume":"6","author":"Lara","year":"2011","journal-title":"Radiat. Oncol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/jnci\/djr512","article-title":"YB-1, the E2F pathway, and regulation of tumor cell growth.","volume":"104","author":"Lasham","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"B104","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1042\/bj20121323","article-title":"YB-1: oncoprotein, prognostic marker and therapeutic target?","volume":"449","author":"Lasham","year":"2013","journal-title":"Biochem. J."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012661","article-title":"Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viability.","volume":"5","author":"Law","year":"2010","journal-title":"PLoS One"},{"key":"B106","first-page":"1118","article-title":"Nanoparticle-based targeted gene therapy for lung cancer.","volume":"6","author":"Lee","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pharmthera.2015.12.001","article-title":"Cancer stem cells in drug resistant lung cancer: targeting cell surface markers and signaling pathways.","volume":"158","author":"Leon","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1002\/hep.29010","article-title":"Long noncoding RNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of extracellular signal\u2013regulated kinase and YB-1 to enhance hepatocarcinogenesis.","volume":"65","author":"Li","year":"2017","journal-title":"Hepatology"},{"key":"B109","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3816\/CLC.2009.n.078","article-title":"Expression of MRP1, BCRP, LRP, and ERCC1 in advanced non\u2013small-cell lung cancer: correlation with response to chemotherapy and survival.","volume":"10","author":"Li","year":"2009","journal-title":"Clin. Lung Cancer"},{"key":"B110","doi-asserted-by":"publisher","first-page":"14642","DOI":"10.18632\/oncotarget.24489","article-title":"Clinicopathological and prognostic significance of Twist overexpression in NSCLC.","volume":"9","author":"Li","year":"2018","journal-title":"Oncotarget"},{"key":"B111","doi-asserted-by":"publisher","first-page":"230","DOI":"10.5301\/jbm.2009.5437","article-title":"Expression of MRP1, BCRP, LRP and ERCC1 as prognostic factors in non-small cell lung cancer patients receiving postoperative cisplatin-based chemotherapy.","volume":"24","author":"Li","year":"2009","journal-title":"Int. J. Biol. Mark."},{"key":"B112","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/82_2010_75","article-title":"Hypoxia and hypoxia inducible factors in cancer stem cell maintenance.","volume":"345","author":"Li","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13875","article-title":"Y-box binding protein-1 promotes tumorigenesis and progression via the epidermal growth factor receptor\/AKT pathway in spinal chordoma.","volume":"110","author":"Liang","year":"2019","journal-title":"Cancer Sci."},{"key":"B114","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1089\/hum.2018.026","article-title":"The oncolytic adenovirus XVir-N-31 as a novel therapy in muscle-invasive bladder cancer.","volume":"30","author":"Lichtenegger","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3187-7","article-title":"YBX1 gene silencing inhibits migratory and invasive potential via CORO1C in breast cancer in vitro.","volume":"17","author":"Lim","year":"2017","journal-title":"BMC Cancer"},{"key":"B116","doi-asserted-by":"publisher","first-page":"34796","DOI":"10.18632\/oncotarget.16276","article-title":"Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer.","volume":"8","author":"Lindquist","year":"2017","journal-title":"Oncotarget"},{"key":"B117","doi-asserted-by":"publisher","first-page":"8722","DOI":"10.26355\/eurrev_201812_16637","article-title":"LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K\/Akt pathway.","volume":"22","author":"Liu","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.yexcr.2016.10.011","article-title":"Hyper-O-GlcNAcylation of YB-1 affects Ser102 phosphorylation and promotes cell proliferation in hepatocellular carcinoma.","volume":"349","author":"Liu","year":"2016","journal-title":"Exp. Cell Res."},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7925219","article-title":"Sex differences in the association between night shift work and the risk of cancers: a meta-analysis of 57 articles.","volume":"2018","author":"Liu","year":"2018","journal-title":"Dis. Mark."},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/srep10159","article-title":"lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer.","volume":"5","author":"Liu","year":"2015","journal-title":"Sci. Rep."},{"key":"B121","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.yexcr.2017.07.039","article-title":"YB-1 expression promotes pancreatic cancer metastasis that is inhibited by microRNA-216a.","volume":"359","author":"Lu","year":"2017","journal-title":"Exp. Cell Res."},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052527","article-title":"YB-1 synthesis is regulated by mTOR signaling pathway.","volume":"7","author":"Lyabin","year":"2012","journal-title":"PLoS One"},{"key":"B123","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/wrna.1200","article-title":"YB-1 protein: functions and regulation.","volume":"5","author":"Lyabin","year":"2014","journal-title":"Wiley Interdiscipl. Rev. RNA"},{"key":"B124","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1074\/jbc.m508937200","article-title":"Reduced stability of mitogen-activated protein kinase kinase-2 mRNA and phosphorylation of poly (A)-binding protein (PABP) in cells overexpressing PABP.","volume":"281","author":"Ma","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B125","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.canlet.2016.01.012","article-title":"Lung cancer stem cells: the root of resistance.","volume":"372","author":"MacDonagh","year":"2016","journal-title":"Cancer Lett."},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.11.015","article-title":"Cancer stem cells: road to therapeutic resistance and strategies to overcome resistance.","author":"Makena","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1093\/nar\/24.10.1873","article-title":"Structural and functional analysis of the human Y-box binding protein (YB-1) gene promoter.","volume":"24","author":"Makino","year":"1996","journal-title":"Nucleic Acids Res."},{"key":"B128","doi-asserted-by":"publisher","first-page":"7195","DOI":"10.1158\/0008-5472.can-05-2339","article-title":"Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agents.","volume":"66","author":"Mantwill","year":"2006","journal-title":"Cancer Res."},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-216","article-title":"YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells.","volume":"11","author":"Mantwill","year":"2013","journal-title":"J. Transl. Med."},{"key":"B130","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4997\/JRCPE.2015.207","article-title":"Survival from malignant mesothelioma: where are we now?","volume":"45","author":"Marshall","year":"2015","journal-title":"J. R. Coll. Phys. Edinburgh"},{"key":"B131","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1074\/jbc.M116.740258","article-title":"Novel Serine 176 phosphorylation of YBX1 activates NF-\u03baB in colon cancer.","volume":"292","author":"Martin","year":"2017","journal-title":"J. Biol. Chem."},{"key":"B132","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-0991-5","article-title":"Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance.","volume":"18","author":"Mashouri","year":"2019","journal-title":"Mol. Cancer"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24401-3","article-title":"Y-box protein-associated acidic protein (YBAP1\/C1QBP) affects the localization and cytoplasmic functions of YB-1.","volume":"8","author":"Matsumoto","year":"2018","journal-title":"Sci. Rep."},{"key":"B134","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","article-title":"The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation.","volume":"36","author":"Mendoza","year":"2011","journal-title":"Trends Biochem. Sci."},{"key":"B135","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.bbrc.2016.10.107","article-title":"Transportin-1-dependent YB-1 nuclear import.","volume":"480","author":"Mordovkina","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B136","doi-asserted-by":"publisher","first-page":"4328","DOI":"10.1096\/fj.201701291RR","article-title":"Exosomes from asbestos-exposed cells modulate gene expression in mesothelial cells.","volume":"32","author":"Munson","year":"2018","journal-title":"FASEB J."},{"key":"B137","doi-asserted-by":"publisher","first-page":"103","DOI":"10.7150\/jgen.20581","article-title":"Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinoma.","volume":"6","author":"Murugesan","year":"2018","journal-title":"J. Genomics"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.jtho.2018.06.011","article-title":"Scientific advances and new frontiers in mesothelioma therapeutics.","volume":"13","author":"Mutti","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"B139","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/HP.S93413","article-title":"The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy.","volume":"3","author":"Muz","year":"2015","journal-title":"Hypoxia"},{"key":"B140","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/14737140.2018.1409624","article-title":"Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer.","volume":"18","author":"Nagasaka","year":"2018","journal-title":"Expert Rev. Anticancer Ther."},{"key":"B141","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/cam4.202","article-title":"A molecular targeting against nuclear factor-\u03baB, as a chemotherapeutic approach for human malignant mesothelioma.","volume":"3","author":"Nishikawa","year":"2014","journal-title":"Cancer Med."},{"key":"B142","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.1074\/jbc.273.11.5997","article-title":"Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene.","volume":"273","author":"Ohga","year":"1998","journal-title":"J. Biol. Chem."},{"key":"B143","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.neo.2017.07.007","article-title":"What\u2019s new in SCLC? a review.","volume":"19","author":"Oronsky","year":"2017","journal-title":"Neoplasia"},{"key":"B144","doi-asserted-by":"publisher","first-page":"7502","DOI":"10.1200\/jco.2015.33.15_suppl.7502","article-title":"Pembrolizumab (MK-3475) in patients (pts) with extensive-stage small cell lung cancer (SCLC): preliminary safety and efficacy results from KEYNOTE-028.","volume":"33","author":"Ott","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"6193","DOI":"10.18632\/oncotarget.14051","article-title":"The tumor-associated YB-1 protein: new player in the circadian control of cell proliferation.","volume":"8","author":"Pagano","year":"2017","journal-title":"Oncotarget"},{"key":"B146","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1016\/j.cellsig.2015.09.001","article-title":"HACE1 mediated K27 ubiquitin linkage leads to YB-1 protein secretion.","volume":"27","author":"Palicharla","year":"2015","journal-title":"Cell Signal."},{"key":"B147","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cmet.2016.07.001","article-title":"Circadian rhythm disruption promotes lung tumorigenesis.","volume":"24","author":"Papagiannakopoulos","year":"2016","journal-title":"Cell Metab."},{"key":"B148","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1440-1843.2008.01447.x","article-title":"Impact of oxidative stress on lung diseases.","volume":"14","author":"Park","year":"2009","journal-title":"Respirology"},{"key":"B149","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-018-0040-3","article-title":"Identification of the tumour transition states occurring during EMT.","volume":"556","author":"Pastushenko","year":"2018","journal-title":"Nature"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0920-z","article-title":"The long noncoding RNA LINC00312 induces lung adenocarcinoma migration and vasculogenic mimicry through directly binding YBX1.","volume":"17","author":"Peng","year":"2018","journal-title":"Mol. Cancer"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-0768-1","article-title":"p90 ribosomal S6 kinase: a potential therapeutic target in lung cancer.","volume":"14","author":"Poomakkoth","year":"2016","journal-title":"J. Transl. Med."},{"key":"B152","doi-asserted-by":"publisher","first-page":"29396","DOI":"10.18632\/oncotarget.5120","article-title":"Critical role of phosphorylation of serine 165 of YBX1 on the activation of NF-\u03baB in colon cancer.","volume":"6","author":"Prabhu","year":"2015","journal-title":"Oncotarget"},{"key":"B153","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1158\/1078-0432.CCR-17-1172","article-title":"Comprehensive pharmacogenomic profiling of malignant pleural mesothelioma identifies a subgroup sensitive to FGFR inhibition.","volume":"24","author":"Quispel-Janssen","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"B154","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1159\/000324209","article-title":"Extracellular YB-1 blockade in experimental nephritis upregulates Notch-3 receptor expression and signaling.","volume":"118","author":"Raffetseder","year":"2011","journal-title":"Nephron Exp. Nephrol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.bbrc.2016.08.064","article-title":"Cold shock protein YB-1 is involved in hypoxia-dependent gene transcription.","volume":"478","author":"Rauen","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B156","doi-asserted-by":"publisher","first-page":"26928","DOI":"10.1074\/jbc.M109.046599","article-title":"YB-1 acts as ligand for Notch-3 receptors and modulates receptor activation.","volume":"284","author":"Rauen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-119","article-title":"GAS5 long non-coding RNA in malignant pleural mesothelioma.","volume":"13","author":"Renganathan","year":"2014","journal-title":"Mol. Cancer"},{"key":"B158","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nature03319","article-title":"Wnt signalling in stem cells and cancer.","volume":"434","author":"Reya","year":"2005","journal-title":"Nature"},{"key":"B159","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1097\/JTO.0000000000000202","article-title":"Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma.","volume":"9","author":"Riquelme","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.drup.2011.03.001","article-title":"Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.","volume":"14","author":"Rohwer","year":"2011","journal-title":"Drug Resist. Updat."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/ng.2405","article-title":"Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.","volume":"44","author":"Rudin","year":"2012","journal-title":"Nat. Genet."},{"key":"B162","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1200\/jop.2015.008201","article-title":"Treatment of small-cell lung cancer: American Society of Clinical Oncology endorsement of the American College of Chest Physicians guideline.","volume":"12","author":"Rudin","year":"2016","journal-title":"J. Oncol. Pract."},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4692081","article-title":"The potential roles of extracellular vesicles in cigarette smoke-associated diseases.","volume":"2018","author":"Ryu","year":"2018","journal-title":"Oxidat. Med. Cell. Longev."},{"key":"B164","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1164\/rccm.201404-0658OC","article-title":"Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio-and chemotherapy.","volume":"190","author":"Schelch","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B165","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1002\/ijc.22512","article-title":"The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance.","volume":"120","author":"Schittek","year":"2007","journal-title":"Int. J. Cancer"},{"key":"B166","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.resinv.2018.11.005","article-title":"DNA repair as an emerging target for COPD-lung cancer overlap.","volume":"57","author":"Sears","year":"2019","journal-title":"Respir. Investig."},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33879-w","article-title":"Fisetin targets YB-1\/RSK axis independent of its effect on ERK signaling: insights from in vitro and in vivo melanoma models.","volume":"8","author":"Sechi","year":"2018","journal-title":"Sci. Rep."},{"key":"B168","doi-asserted-by":"publisher","first-page":"8952","DOI":"10.1002\/jcp.26830","article-title":"Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas.","volume":"233","author":"Sementino","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev-pathol-012513-104720","article-title":"Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology.","volume":"9","author":"Semenza","year":"2014","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"B170","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nrc3281","article-title":"Therapeutics: siRNAs jump the hurdle.","volume":"12","author":"Seton-Rogers","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"B171","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/2211-5463.12004","article-title":"Overexpression of YB 1 C-terminal domain inhibits proliferation, angiogenesis and tumorigenicity in a SK-BR-3 breast cancer xenograft mouse model.","volume":"6","author":"Shi","year":"2016","journal-title":"FEBS Open Bio."},{"key":"B172","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1002\/mc.22120","article-title":"A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer.","volume":"54","author":"Shi","year":"2015","journal-title":"Mol. Carcinog."},{"key":"B173","first-page":"3151","article-title":"Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer.","volume":"7","author":"Shibahara","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"B174","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/pros.22799","article-title":"Targeting ribosomal S6 kinases\/Y-box binding protein-1 signaling improves cellular sensitivity to taxane in prostate cancer.","volume":"74","author":"Shiota","year":"2014","journal-title":"Prostate"},{"key":"B175","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1158\/0008-5472.CAN-07-2981","article-title":"Twist promotes tumor cell growth through YB-1 expression.","volume":"68","author":"Shiota","year":"2008","journal-title":"Cancer Res."},{"key":"B176","doi-asserted-by":"publisher","first-page":"E142","DOI":"10.1111\/j.1464-410X.2010.09810.x","article-title":"Twist1 and Y-box-binding protein-1 promote malignant potential in bladder cancer cells.","volume":"108","author":"Shiota","year":"2011","journal-title":"BJU Int."},{"key":"B177","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1111\/j.1349-7006.2010.01598.x","article-title":"P300\/CBP-associated factor regulates Y-box binding protein-1 expression and promotes cancer cell growth, cancer invasion and drug resistance.","volume":"101","author":"Shiota","year":"2010","journal-title":"Cancer Sci."},{"key":"B178","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.addr.2013.11.006","article-title":"Stable RNA nanoparticles as potential new generation drugs for cancer therapy.","volume":"66","author":"Shu","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B179","doi-asserted-by":"publisher","first-page":"E8987","DOI":"10.1073\/pnas.1712108114","article-title":"Broad role for YBX1 in defining the small noncoding RNA composition of exosomes.","volume":"114","author":"Shurtleff","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B180","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.ymthe.2019.05.020","article-title":"microRNA-215-5p treatment suppresses mesothelioma progression via the MDM2-p53 signaling axis.","volume":"27","author":"Singh","year":"2019","journal-title":"Mol. Ther."},{"key":"B181","first-page":"3080","article-title":"Gene expression profiling of malignant mesothelioma.","volume":"9","author":"Singhal","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"B182","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1128\/mcb.25.8.3317-3323.2005","article-title":"YB-1 autoregulates translation of its own mRNA at or prior to the step of 40S ribosomal subunit joining.","volume":"25","author":"Skabkina","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"18191","DOI":"10.1074\/jbc.m209073200","article-title":"Poly (A)-binding protein positively affects YB-1 mRNA translation through specific interaction with YB-1 mRNA.","volume":"278","author":"Skabkina","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B184","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1023\/a:1012292230480","article-title":"The expression of P-glycoprotein and multidrug resistance proteins 1 and 2 (MRP1 and MRP2) in human malignant mesothelioma.","volume":"12","author":"Soini","year":"2001","journal-title":"Ann. Oncol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1083\/jcb.201411047","article-title":"YB-1 regulates stress granule formation and tumor progression by translationally activating G3BP1.","volume":"208","author":"Somasekharan","year":"2015","journal-title":"J. Cell Biol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1038\/sj.emboj.7600830","article-title":"Proteasome-mediated cleavage of the Y-box-binding protein 1 is linked to DNA-damage stress response.","volume":"24","author":"Sorokin","year":"2005","journal-title":"EMBO J."},{"key":"B187","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/med.21510","article-title":"Small-molecule inhibitors of multidrug resistance-associated protein 1 and related processes: a historic approach and recent advances.","volume":"39","author":"Stefan","year":"2019","journal-title":"Med. Res. Rev."},{"key":"B188","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1038\/sj.onc.1208386","article-title":"YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) gene.","volume":"24","author":"Stein","year":"2005","journal-title":"Oncogene"},{"key":"B189","doi-asserted-by":"publisher","first-page":"28562","DOI":"10.1074\/jbc.m100311200","article-title":"Hyperthermia-induced nuclear translocation of transcription factor YB-1 leads to enhanced expression of multidrug resistance-related ABC transporters.","volume":"276","author":"Stein","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2202","article-title":"Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells.","volume":"10","author":"Stratford","year":"2008","journal-title":"Breast Cancer Res."},{"key":"B191","doi-asserted-by":"crossref","DOI":"10.1186\/bcr1767","article-title":"Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy.","volume":"9","author":"Stratford","year":"2007","journal-title":"Breast Cancer Res."},{"key":"B192","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1158\/0008-5472.CAN-18-0222","article-title":"Silencing of long non-coding RNA MIR22HG triggers cell survival\/death signaling via oncogenes YBX1, MET, and p21 in lung cancer.","volume":"78","author":"Su","year":"2018","journal-title":"Cancer Res."},{"key":"B193","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejcb.2018.02.003","article-title":"YBX1 at the crossroads of non-coding transcriptome, exosomal, and cytoplasmic granular signaling.","volume":"97","author":"Suresh","year":"2018","journal-title":"Eur. J. Cell Biol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1038\/sj.onc.1208590","article-title":"Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells.","volume":"24","author":"Sutherland","year":"2005","journal-title":"Oncogene"},{"key":"B195","doi-asserted-by":"crossref","first-page":"S1966","DOI":"10.21037\/jtd.2018.04.106","article-title":"Malignant pleural mesothelioma: main topics of American Society of Clinical Oncology clinical practice guidelines for diagnosis and treatment.","volume":"10","author":"Szolkowska","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-205","article-title":"Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma.","volume":"13","author":"Tabata","year":"2013","journal-title":"BMC Cancer"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-33","article-title":"High prevalence of Y-box protein-1\/p18 fragment in plasma of patients with malignancies of different origin.","volume":"14","author":"Tacke","year":"2014","journal-title":"BMC Cancer"},{"key":"B198","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1136\/thoraxjnl-2017-210670","article-title":"Effective silencing of ENaC by siRNA delivered with epithelial-targeted nanocomplexes in human cystic fibrosis cells and in mouse lung.","volume":"73","author":"Tagalakis","year":"2018","journal-title":"Thorax"},{"key":"B199","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00262-012-1356-8","article-title":"YB-1 suppression induces STAT3 proteolysis and sensitizes renal cancer to interferon-\u03b1.","volume":"62","author":"Takeuchi","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"key":"B200","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.yexcr.2018.07.009","article-title":"Mechanism responsible for inhibitory effect of indirubin 3\u2019-oxime on anticancer agent-induced YB-1 nuclear translocation in HepG2 human hepatocellular carcinoma cells.","volume":"370","author":"Tanaka","year":"2018","journal-title":"Exp. Cell Res."},{"key":"B201","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.bbrc.2016.08.129","article-title":"Four nucleocytoplasmic-shuttling proteins and p53 interact specifically with the YB-NLS and are involved in anticancer reagent-induced nuclear localization of YB-1.","volume":"478","author":"Tanaka","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B202","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1158\/2326-6066.CIR-18-0648","article-title":"Targeting the YB-1\/PD-L1 axis to enhance chemotherapy and antitumor immunity.","volume":"7","author":"Tao","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19082441","article-title":"Stress-induced phosphorylation of nuclear YB-1 depends on nuclear trafficking of p90 Ribosomal S6 Kinase.","volume":"19","author":"Tiwari","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B204","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1158\/0008-5472.can-09-3155","article-title":"Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance.","volume":"70","author":"To","year":"2010","journal-title":"Cancer Res."},{"key":"B205","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1179\/oeh.2004.10.1.22","article-title":"Global use of asbestos and the incidence of mesothelioma.","volume":"10","author":"Tossavainen","year":"2004","journal-title":"Int. J. Occup. Environ. Health"},{"key":"B206","doi-asserted-by":"publisher","first-page":"31694","DOI":"10.1074\/jbc.m200266200","article-title":"p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression.","volume":"277","author":"Uramoto","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1186\/1478-811X-11-63","article-title":"Cold shock Y-box protein-1 proteolysis autoregulates its transcriptional activities.","volume":"11","author":"van Roeyen","year":"2013","journal-title":"Cell Commun. Signal."},{"key":"B208","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/S1470-2045(17)30621-6","article-title":"Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.","volume":"18","author":"van Zandwijk","year":"2017","journal-title":"Lancet Oncol."},{"key":"B209","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.drudis.2017.03.004","article-title":"Exosomes: a new horizon in lung cancer.","volume":"22","author":"Vanni","year":"2017","journal-title":"Drug Discov. Today"},{"key":"B210","first-page":"514","article-title":"Cancer immunotherapy, part 3: challenges and future trends.","volume":"42","author":"Ventola","year":"2017","journal-title":"Pharm. Ther."},{"key":"B211","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071374","article-title":"The between now and then of lung cancer chemotherapy and immunotherapy.","volume":"18","author":"Visconti","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B212","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/jco.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"B213","first-page":"95","article-title":"Prognostic relevance of c-Myc and caspase-3 for patients with non-small cell lung cancer.","volume":"7","author":"Volm","year":"2000","journal-title":"Oncol. Rep."},{"key":"B214","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-017-3011-3","article-title":"Silencing of Y-box binding protein-1 by RNA interference inhibits proliferation, invasion, and metastasis, and enhances sensitivity to cisplatin through NF-\u03baB signaling pathway in human neuroblastoma SH-SY5Y cells.","volume":"433","author":"Wang","year":"2017","journal-title":"Mol. Cell. Biochem."},{"key":"B215","first-page":"1365","article-title":"Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.","volume":"12","author":"Wang","year":"2004","journal-title":"Oncol. Rep."},{"key":"B216","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3892\/etm.2017.4546","article-title":"Antimicrobial peptide LL-37 promotes the viability and invasion of skin squamous cell carcinoma by upregulating YB-1.","volume":"14","author":"Wang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"B217","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.2147\/CMAR.S178380","article-title":"miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins.","volume":"10","author":"Wang","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"B218","first-page":"265","article-title":"Drug resistance mechanisms in non-small cell lung carcinoma.","volume":"2","author":"Wangari-Talbot","year":"2013","journal-title":"J. Cancer Res. Updates"},{"key":"B219","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/s1535-6108(02)00045-4","article-title":"Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma.","volume":"1","author":"Weeraratna","year":"2002","journal-title":"Cancer Cell"},{"key":"B220","doi-asserted-by":"publisher","first-page":"59556","DOI":"10.18632\/oncotarget.10006","article-title":"Long non-coding RNA stabilizes the Y-box-binding protein 1 and regulates the epidermal growth factor receptor to promote lung carcinogenesis.","volume":"7","author":"Wei","year":"2016","journal-title":"Oncotarget"},{"key":"B221","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.bbrc.2017.09.132","article-title":"A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.","volume":"493","author":"Wen","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B222","doi-asserted-by":"publisher","first-page":"161.e1","DOI":"10.1016\/j.cllc.2019.02.011","article-title":"EGFR gene polymorphism predicts improved outcome in patients With EGFR mutation-positive non-small cell lung cancer treated with erlotinib.","volume":"20","author":"Winther-Larsen","year":"2019","journal-title":"Clin. Lung Cancer"},{"key":"B223","first-page":"290","article-title":"The Y-box factors: a family of nucleic acid binding proteins conserved from Escherichia coli to man.","volume":"4","author":"Wolffe","year":"1992","journal-title":"New Biol."},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020603","article-title":"Prognostic association of YB-1 expression in breast cancers: a matter of antibody.","volume":"6","author":"Woolley","year":"2011","journal-title":"PLoS One"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1038\/srep09520","article-title":"Suberoylanilide hydroxamic acid treatment reveals crosstalks among proteome, ubiquitylome and acetylome in non-small cell lung cancer A549 cell line.","volume":"5","author":"Wu","year":"2015","journal-title":"Sci. Rep."},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-018-0221-7","article-title":"TP53TG1 enhances cisplatin sensitivity of non-small cell lung cancer cells through regulating miR-18a\/PTEN axis.","volume":"8","author":"Xiao","year":"2018","journal-title":"Cell Biosci."},{"key":"B227","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.biopha.2016.01.037","article-title":"Y-box-binding protein 1 promotes tumor progression and inhibits cisplatin chemosensitivity in esophageal squamous cell carcinoma.","volume":"79","author":"Xu","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"B228","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00280-017-3355-0","article-title":"Cisplatin induces expression of drug resistance-related genes through c-jun N-terminal kinase pathway in human lung cancer cells.","volume":"80","author":"Xu","year":"","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B229","doi-asserted-by":"publisher","first-page":"65946","DOI":"10.18632\/oncotarget.19583","article-title":"YBX1 promotes tumor growth by elevating glycolysis in human bladder cancer.","volume":"8","author":"Xu","year":"","journal-title":"Oncotarget"},{"key":"B230","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/mt.2014.197","article-title":"miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1.","volume":"23","author":"Xu","year":"2015","journal-title":"Mol. Ther."},{"key":"B231","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00432-002-0386-6","article-title":"Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer.","volume":"128","author":"Yahata","year":"2002","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B232","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3892\/ijo.2017.4031","article-title":"Nuclear expression of Y box binding-1 is important for resistance to chemotherapy including gemcitabine in TP53-mutated bladder cancer.","volume":"51","author":"Yamashita","year":"2017","journal-title":"Int. J. Oncol."},{"key":"B233","doi-asserted-by":"publisher","first-page":"12611","DOI":"10.1073\/pnas.1006542107","article-title":"Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation.","volume":"107","author":"Yang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B234","first-page":"10847","article-title":"MicroRNA-137 inhibits cell migration and invasion by targeting bone morphogenetic protein-7 (BMP7) in non-small cell lung cancer cells.","volume":"8","author":"Yang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"B235","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrc.2017.42","article-title":"Novel insights into mesothelioma biology and implications for therapy.","volume":"17","author":"Yap","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"B236","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/s0006-291x(03)00296-1","article-title":"Regulation of YB-1 gene expression by GATA transcription factors.","volume":"303","author":"Yokoyama","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B237","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jconrel.2017.10.025","article-title":"Multifunctional nanoparticles co-delivering EZH2 siRNA and etoposide for synergistic therapy of orthotopic non-small-cell lung tumor.","volume":"268","author":"Yuan","year":"2017","journal-title":"J. Control. Release"},{"key":"B238","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2147\/DDDT.S43184","article-title":"Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a phase II, randomized study.","volume":"7","author":"Zarogoulidis","year":"2013","journal-title":"Drug Design Dev. Ther."},{"key":"B239","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.3892\/ol.2014.2608","article-title":"mTOR pathway: a current, up-to-date mini-review (Review).","volume":"8","author":"Zarogoulidis","year":"2014","journal-title":"Oncol. Lett."},{"key":"B240","doi-asserted-by":"publisher","first-page":"82139","DOI":"10.18632\/oncotarget.10080","article-title":"YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma.","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1177\/1073274818769849","article-title":"LncRNA DANCR promotes lung cancer by sequestering miR-216a.","volume":"25","author":"Zhen","year":"2018","journal-title":"Cancer Control"},{"key":"B242","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/abbs\/gmp092","article-title":"Discovery of YB-1 as a new immunological target in neuroblastoma by vaccination in the context of regulatory T cell blockade.","volume":"41","author":"Zheng","year":"2009","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"B243","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/abbs\/gms089","article-title":"YB-1 immunization combined with regulatory T-cell depletion induces specific T-cell responses that protect against neuroblastoma in the early stage.","volume":"44","author":"Zheng","year":"2012","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"B244","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.canlet.2017.08.003","article-title":"The biology, function and clinical implications of exosomes in lung cancer.","volume":"407","author":"Zhou","year":"","journal-title":"Cancer Lett."},{"key":"B245","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.yexcr.2017.10.009","article-title":"High YBX1 expression indicates poor prognosis and promotes cell migration and invasion in nasopharyngeal carcinoma.","volume":"361","author":"Zhou","year":"","journal-title":"Exp. Cell Res."},{"key":"B246","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1038\/bjc.2014.220","article-title":"Multipoint targeting of the PI3K\/mTOR pathway in mesothelioma.","volume":"110","author":"Zhou","year":"2014","journal-title":"Br. J. Cancer"},{"key":"B247","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1177\/1753465816654873","article-title":"Notch signaling in lung diseases: focus on Notch1 and Notch3.","volume":"10","author":"Zong","year":"2016","journal-title":"Ther. Adv. Respir. Dis."}],"updated-by":[{"DOI":"10.3389\/fcell.2019.00293","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000}}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2019.00221\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T06:49:57Z","timestamp":1574405397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2019.00221\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":247,"alternative-id":["10.3389\/fcell.2019.00221"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2019.00221","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fcell.2019.00293","asserted-by":"object"}]},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,1]]},"article-number":"221"}}